Search Results - "Massicard, S."
-
1
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
Published in Cancer Immunology, Immunotherapy (01-05-2004)“…This study was conducted in prostate cancer patients in biochemical relapse after radical prostatectomy, to assess the feasibility, safety, and immunogenicity…”
Get full text
Journal Article -
2
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
Published in Cancer Immunology, Immunotherapy (01-07-2006)“…The aim of the present phase I/II study was to evaluate the safety, immune responses and clinical activity of a vaccine based on autologous dendritic cells…”
Get full text
Journal Article -
3
Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients
Published in Journal of immunotherapy (1997) (2008)“…The primary goal of cancer vaccines is to induce CD8+ T cells specific for tumor-associated antigens (TAA) but the characterization of these cells has been…”
Get full text
Journal Article -
4
An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV18 transcription
Published in EMBO reports (01-11-2000)“…Recent studies have reported new mechanisms that mediate the transcriptional synergy of strong tissue‐specific enhancers, involving the cooperative assembly of…”
Get full text
Journal Article -
5
An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription
Published in EMBO reports (01-11-2000)“…Recent studies have reported new mechanisms that mediate the transcriptional synergy of strong tissue-specific enhancers, involving the cooperative assembly of…”
Get full text
Journal Article -
6
-
7